Manh-Cuong Vo

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine

Hyun Jin Park, Gun-Young Jang, Young Seob Kim et al. · Journal for ImmunoTherapy of Cancer · 2019 · 46 citations · Full text

Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma

Thanh-Nhan Nguyen-Pham, Sung‐Hoon Jung, Manh-Cuong Vo et al. · Journal of Immunotherapy · 2015 · 42 citations

Dendritic Cell, Immunology, Immune Regulation +23

Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model

Jaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung‐Hoon Jung et al. · Cellular and Molecular Immunology · 2021 · 42 citations · Full text

Cancer Immunosurveillance, Antimyeloma Effect, Immunology +9

Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model

Manh-Cuong Vo, Thanh-Nhan Nguyen-Pham, Hyunju Lee et al. · Oncotarget · 2017 · 39 citations · Full text

Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma

Manh-Cuong Vo, Sung‐Hoon Jung, Tan-Huy Chu et al. · Frontiers in Immunology · 2018 · 38 citations · Full text